EPISODE · Nov 21, 2023 · 8 MIN
Why should people living with HIV and other immunocompromising conditions be included in clinical trials similar to the RBDCOV trial?
from RBDCOV Talks · host RBDCOV
Shed light on immunocompromised clinical trials inclusion. 🦠 Why involve those with HIV? Join our conversation with Juanfran C and Arda from EATG to understand better the significance for a more inclusive and effective future.
Embed this episode
Ready to play
Why should people living with HIV and other immunocompromising conditions be included in clinical trials similar to the RBDCOV trial?
0:00
8:19
1×
No transcript for this episode yet
Similar Episodes
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of RBDCOV Talks?
This episode is 8 minutes long.
When was this RBDCOV Talks episode published?
This episode was published on November 21, 2023.
Can I download this RBDCOV Talks episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!